Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ULTRALIFE CORP Director's Dealing 2021

Oct 22, 2021

34105_dirs_2021-10-22_2fdafa7e-7f23-4285-abd6-cc8a053d9ba6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2021-10-20

Reporting Person: FAIN PHILIP A (CFO and Treasurer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-10-20 Common Stock (Right to Buy) $6.9694 A 20000 Acquired 2028-10-20 Common Stock (20000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock; $.10 par value 118160 Direct

Footnotes

F1: These options vest as follows: 6,667 shares on 10-20-2022; 6,667 shares on10-20-2023; 6,666 shares on 10-20-2024.